Liposarcoma Clinical Trials 2022

Browse 37 Liposarcoma Medical Studies Across 170 Cities

6 Phase 3 Trial · 488 Liposarcoma Clinics

Reviewed by Michael Gill, B. Sc.
25 Liposarcoma Clinical Trials Near Me
New York, NY
Houston, TX
Houston, TX
Houston, TX
More Trial Locations
An interactive map to display trial locations for Columbia University Irving Medical Center / NewYork-Presbyterian, Houston Methodist Hospital, Texas Children's Hospital, The University of Texas MD Anderson Cancer Center, and 267 more locations.
Most Popular References for Liposarcoma Clinical Trials
Frequency
Citation
Top Hospitals for Liposarcoma Clinical Trials
Location
Active Liposarcoma Clinical Trials
All Time Trials for Liposarcoma
First Recorded Liposarcoma Trial
Trials
Memorial Sloan Kettering Cancer Center, New York, New York
9
10
2010
Dana-Farber Cancer Institute, Boston, Massachusetts
5
13
1997
Top Treatments for Liposarcoma Clinical Trials
Treatment Name
Active Liposarcoma Clinical Trials
All Time Trials for Liposarcoma
First Recorded Liposarcoma Trial
Trials
Top Cities for Liposarcoma Clinical Trials
City
Active Liposarcoma Clinical Trials
Top Active Site for Liposarcoma Clinical Trials
Trial List
New York, New York
26
Memorial Sloan Kettering Cancer Center
Boston, Massachusetts
20
Dana-Farber Cancer Institute
Houston, Texas
18
MD Anderson Cancer Center
Saint Louis, Missouri
17
Washington University School of Medicine
Most Recent Liposarcoma Clinical Trials
Clinical Trial
Began Recruiting Date
Phase
2/14/2022
Phase 1
Phase 3 Liposarcoma Clinical Trials
Clinical Trial
Began Recruiting Date
Phase
7/14/2021
Phase 3
Pediatric Liposarcoma Clinical Trials
Senior Friendly Liposarcoma Clinical Trials
Clinical Trial
Began Recruiting Date
Phase
2/14/2022
Phase 1
Recently Completed Studies with FDA Approved Treatments for Liposarcoma
Treatment
Year
Mechanism of Action
Sponsor
Active Liposarcoma Clinical Trials
letetresgene autoleucel (GSK3377794)
2016
GlaxoSmithKline
0

About The Author

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 11th, 2021

Last Reviewed: August 6th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.